CN1374107A - Chinese medicine for treating prostatitis, prostate hyperplasia and prostatauxe - Google Patents
Chinese medicine for treating prostatitis, prostate hyperplasia and prostatauxe Download PDFInfo
- Publication number
- CN1374107A CN1374107A CN01145356A CN01145356A CN1374107A CN 1374107 A CN1374107 A CN 1374107A CN 01145356 A CN01145356 A CN 01145356A CN 01145356 A CN01145356 A CN 01145356A CN 1374107 A CN1374107 A CN 1374107A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- chinese medicine
- prostatitis
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese medicine for treating prostatitis, prostate hyperplasia and prostatauxe is prepared with astragalus root, Codonopsis Pilosulae spatrolobus stem, red peony root, peach kernel and other 18 Chinese medicinal materials. The said Chinese medicinal materials are soaked in boiled water for 1 hr, decocted for 35 min and filtered to obtain the Chinese medicine decoction. The medicine may be also further produced into medicine capsule for convenient taking. The medicine has high curative effect and can cure the said diseases radically.
Description
Technical field
The present invention relates to a kind of medical technical field, be specifically related to a kind of Chinese medicine for the treatment of prostatosis.
Background technology
Doctor trained in Western medicine claims that prostatitis, prostatic hyperplasia and prostate hyperplasia are difficulty in urination disease, it is one of common ailment of middle-aged and old, it is multiple to cause the cause of disease to have, because it is tired or experience cold or seven emotions drastic change or pig out irritable food and all can excite prostata tissue, unexpected congested swelling compressing urethra, cause dysuria, form the difficulty in urination.Owing to kidney and bladder qi dysfunction cause hypourocrinia, acraturesis, the inaccessible obstructed or drop of urine and be short of, the urine rheology urine carefully also can occur and flow the interrupter, causes urine retention, forms the difficulty in urination.The difficulty in urination has substantial connection in lung spleen kidney liver; urine unobstructed; depend on the gasification of kidney and bladder; from the whole relation between the internal organs, and it is also good in the gasification of three warmers and the logical accent of lung spleen kidney that the absorption of water liquid operation is drained, and transfers and evaporate; the main gasification at bladder in sick position of primary disease; from the whole relation between the internal organs, the absorption of water liquid operation drainage also depends on the gasification of three warmers and the logical accent of lung spleen kidney, transfers and evaporates.The sick position of primary disease is main at bladder, but closely related with three warmers lung spleen kidney, the gas of the part of the body cavity above the diaphragm housing the heart and lungs do not change when duty in lung, lung dereliction of duty then can not regulating fluid apssage, following defeated bladder, middle Jiao's gas are not changed when blaming in spleen, deficiency-weakness of spleen-QI then can not ascending the clear and descending the turbid, and the gas of the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels is not changed when the void that blame in kidney yang, QI failing to transform into body fluid, deficiency of kidney yin, the exhaustion of water mansion, all can cause difficulty in urination stagnation of QI due to depression of the liver, make qiactivity of triple energizer unfavorable, also can send out the difficulty in urination, stagnation of QI due to depression of the liver, make qiactivity of triple energizer unfavorable, also can send out the difficulty in urination, also have urinary tract to block in addition, blood stasis loses essence, or lump calculus, cloudy plug urinary tract, difficulty in urination is to discharge, because of forming the difficulty in urination etc.
The Chinese patent medicine of treatment prostatitis, prostatic hyperplasia, prostate hyperplasia has QIANLIEKANG etc. at present, but therapeutic effect is not remarkable, and cure rate is low.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine for the treatment of prostatitis, prostatic hyperplasia, prostate hyperplasia, have replenishing QI to invigorate the spleen, warming and recuperating the kidney-YANG, removing blood stasis, the purging FU-organs of regulating the flow of vital energy, nourishing YIN to lower pathogenic fire, the effect of activating QI to promote diuresis cures mainly the cloudy two empty blood agglomeration of gas in the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels, damp and hot friendship resistance, functioning of bladder is had no right, sagging distention in the smaller abdomen, and water channel is obstructed, urine urgency-frequency, urine retention, urine is waited for, urinate unable, diseases such as urine retention.
The concrete technical scheme of the present invention is: active ingredient and proportioning are the Radix Astragali 50 grams, Radix Codonopsis 40 grams, Caulis Spatholobi 50 grams, Radix Paeoniae Rubra 30 grams, Semen Persicae 30 grams, Herba Artemisiae Anomalae 30 grams, Radix Salviae Miltiorrhizae 30 grams, Hirudo 10 grams, river cattle sunset 30 restrain, Lignum Aquilariae Resinatum 6 grams, the Radix Linderae 30 grams, Semen Vaccariae 40 grams, Rhizoma Alismatis 30 grams, Semen Plantaginis 40 grams, Spina Gleditsiae 30 grams, Cortex Phellodendri 20 grams, the Rhizoma Anemarrhenae 20 grams, 1 pair of Gryllus Chinensis, Radix Et Rhizoma Rhei's 10 grams, field dobber 40 grams, Fructus Ligustri Lucidi 40 grams, Cortex Cinnamomi 5 grams, Radix Glycyrrhizae 30 grams.
Suffer from the hematuria symptom simultaneously and can in former Chinese medicinal ingredients, add Rhizoma Imperatae 50 grams, each 40 gram of bright large and small Ji, curative effect is more remarkable.
Suffer from the calculus symptom simultaneously and can in former Chinese medicinal ingredients, add Herba Lysimachiae 50 grams, Folium Pyrrosiae 50 grams, Spora Lygodii 30 grams, curative effect is more remarkable.
Preparation method of the present invention is: the Chinese crude drug that will prepare according to the above ratio soaked 1 hour with boiled water, heated then, and the boiling back is with 35 minutes at a simmer, filtration get final product Chinese medicine of the present invention.About 150 grams of filtrate divide each 1 time sooner or later, and body weak person can divide early evening at noon each 1 time, fries in shallow oil every day 1 time, eats one day, and every pair of medicine is fried in shallow oil three times, obeys all uncooked, cold and bite foods of three natural taboo for treatment, the lighter's three secondary recoveries from illness, and weight person 5-6 is secondary to fully recover.Also this medicine can be ground into powder and make powder and incapsulate, take more conveniently, obey the 5-6 grain at every turn, obey every day three times, the weak decrement of body is taken, with decoction the lighter 9 days, and heavy person recovery from illness in 18 days, with capsule the lighter 15 days, heavy person recovery from illness in 30 days went root not rebound.
Year clinical observation 500 routine patients surplus 30, the male, between the age 40-60, through taking the efficacy result of treatment prostatitis, hypertrophy, outgrowth Chinese medicine, the lighter's three secondary recoveries from illness, weight person 5-6 is secondary to fully recover.Cure 479 examples, 12 examples that take a turn for the better, invalid 9 examples, total effective rate is more than 98%.
Claims (3)
1, a kind of treatment prostatitis, hypertrophy, loose Chinese medicine is characterized in that: active ingredient and proportioning are the Radix Astragali 50 grams, Radix Codonopsis 40 grams, Caulis Spatholobi 50 grams, Radix Paeoniae Rubra 30 grams, Semen Persicae 30 grams, Herba Artemisiae Anomalae 30 grams, Radix Salviae Miltiorrhizae 30 grams, Hirudo 10 grams, river cattle sunset 30 restrain, Lignum Aquilariae Resinatum 6 grams, the Radix Linderae 30 grams, Semen Vaccariae 40 grams, Rhizoma Alismatis 30 grams, Semen Plantaginis 40 grams, Spina Gleditsiae 30 grams, Cortex Phellodendri 20 grams, the Rhizoma Anemarrhenae 20 grams, 1 pair of Gryllus Chinensis, Radix Et Rhizoma Rhei's 10 grams, field dobber 40 grams, Fructus Ligustri Lucidi 40 grams, Cortex Cinnamomi 5 grams, Radix Glycyrrhizae 30 grams, to soak 1 hour with boiled water by the above-mentioned Chinese crude drug for preparing in proportion, heating then, boiling back be with 35 minutes at a simmer, filtration get final product Chinese medicine of the present invention.
2, a kind of Chinese medicine for the treatment of prostatitis, prostatic hyperplasia, prostate hyperplasia according to claim 1 is characterized in that: add Rhizoma Imperatae 50 grams in the Chinese crude drug for preparing, each 40 gram of bright large and small Ji.
3, a kind of Chinese medicine for the treatment of prostatitis, prostatic hyperplasia, prostate hyperplasia according to claim 1 is characterized in that: add Herba Lysimachiae 50 grams in the Chinese crude drug for preparing, Folium Pyrrosiae 50 grams, Spora Lygodii 30 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011453567A CN1150933C (en) | 2001-12-29 | 2001-12-29 | Chinese medicine for treating prostatitis, prostate hyperplasia and prostatauxe |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011453567A CN1150933C (en) | 2001-12-29 | 2001-12-29 | Chinese medicine for treating prostatitis, prostate hyperplasia and prostatauxe |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1374107A true CN1374107A (en) | 2002-10-16 |
| CN1150933C CN1150933C (en) | 2004-05-26 |
Family
ID=4678151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011453567A Expired - Fee Related CN1150933C (en) | 2001-12-29 | 2001-12-29 | Chinese medicine for treating prostatitis, prostate hyperplasia and prostatauxe |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1150933C (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1305505C (en) * | 2005-10-17 | 2007-03-21 | 高春 | Medicament for treating prostatauxe inflammation |
| CN100346815C (en) * | 2004-11-08 | 2007-11-07 | 北京万邦医药投资有限公司 | Chinese medicine composition for preventing and treating senile dementia and prostate hypertrophy |
| CN100394939C (en) * | 2004-01-06 | 2008-06-18 | 甘肃独一味生物制药股份有限公司 | Pure Chinese medicine oral preparation for treating prostate disease and its preparation metod |
| CN101164581B (en) * | 2006-10-17 | 2010-05-19 | 臧育增 | Traditional Chinese medicine for treating acute and chronic prostate disease and preparation technology thereof |
| CN101342281B (en) * | 2007-07-13 | 2011-01-19 | 李鸿英 | Medicine for treating prostatosis and method for preparing same |
| CN102861302A (en) * | 2011-07-08 | 2013-01-09 | 余毅 | Traditional Chinese preparation for treating benign prostatic hyperplasia and preparation method for traditional Chinese preparation |
| CN103330897A (en) * | 2013-07-04 | 2013-10-02 | 谢益新 | Pharmaceutical composition for treating renal and ureteral calculus |
| CN103877330A (en) * | 2014-04-22 | 2014-06-25 | 王艳和 | Traditional Chinese medicine composition for treating uroschesis |
| CN103908637A (en) * | 2014-04-17 | 2014-07-09 | 孟凡英 | Traditional Chinese medicine granule for hip bath of chronic prostatitis |
| CN104758754A (en) * | 2015-04-29 | 2015-07-08 | 许艳 | Medicine for treating kidney qi deficiency benign prostate hyperplasia and preparation method thereof |
| CN105079702A (en) * | 2015-09-07 | 2015-11-25 | 徐辉 | Medicine for treating prostatitis |
| CN105920544A (en) * | 2016-06-27 | 2016-09-07 | 许建成 | Traditional Chinese medicinal preparation for treating prostate hyperplasia and preparation method thereof |
| CN109432319A (en) * | 2018-12-16 | 2019-03-08 | 王殿玲 | A kind of Chinese medicine for treating hyperplasia of prostate |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101628060B (en) * | 2009-08-05 | 2011-07-20 | 刘志美 | Medicinal decoction used for treating prostate hyperplasia |
-
2001
- 2001-12-29 CN CNB011453567A patent/CN1150933C/en not_active Expired - Fee Related
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100394939C (en) * | 2004-01-06 | 2008-06-18 | 甘肃独一味生物制药股份有限公司 | Pure Chinese medicine oral preparation for treating prostate disease and its preparation metod |
| CN100346815C (en) * | 2004-11-08 | 2007-11-07 | 北京万邦医药投资有限公司 | Chinese medicine composition for preventing and treating senile dementia and prostate hypertrophy |
| CN1305505C (en) * | 2005-10-17 | 2007-03-21 | 高春 | Medicament for treating prostatauxe inflammation |
| CN101164581B (en) * | 2006-10-17 | 2010-05-19 | 臧育增 | Traditional Chinese medicine for treating acute and chronic prostate disease and preparation technology thereof |
| CN101342281B (en) * | 2007-07-13 | 2011-01-19 | 李鸿英 | Medicine for treating prostatosis and method for preparing same |
| CN102861302B (en) * | 2011-07-08 | 2014-05-07 | 余毅 | Traditional Chinese preparation for treating benign prostatic hyperplasia and preparation method for traditional Chinese preparation |
| CN102861302A (en) * | 2011-07-08 | 2013-01-09 | 余毅 | Traditional Chinese preparation for treating benign prostatic hyperplasia and preparation method for traditional Chinese preparation |
| CN103330897A (en) * | 2013-07-04 | 2013-10-02 | 谢益新 | Pharmaceutical composition for treating renal and ureteral calculus |
| CN103908637A (en) * | 2014-04-17 | 2014-07-09 | 孟凡英 | Traditional Chinese medicine granule for hip bath of chronic prostatitis |
| CN103877330A (en) * | 2014-04-22 | 2014-06-25 | 王艳和 | Traditional Chinese medicine composition for treating uroschesis |
| CN104758754A (en) * | 2015-04-29 | 2015-07-08 | 许艳 | Medicine for treating kidney qi deficiency benign prostate hyperplasia and preparation method thereof |
| CN105079702A (en) * | 2015-09-07 | 2015-11-25 | 徐辉 | Medicine for treating prostatitis |
| CN105920544A (en) * | 2016-06-27 | 2016-09-07 | 许建成 | Traditional Chinese medicinal preparation for treating prostate hyperplasia and preparation method thereof |
| CN109432319A (en) * | 2018-12-16 | 2019-03-08 | 王殿玲 | A kind of Chinese medicine for treating hyperplasia of prostate |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1150933C (en) | 2004-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1150933C (en) | Chinese medicine for treating prostatitis, prostate hyperplasia and prostatauxe | |
| CN103071023B (en) | Traditional Chinese medicinal composition for effectively treating diabetes | |
| CN102430079A (en) | Traditional Chinese medicine composite for treating stranguria | |
| CN103816428B (en) | A kind of preparation of effective treatment diabetes | |
| CN100998722B (en) | Oral traditional Chinese medicine for treating delayed menstrual ciycle menalgia | |
| CN102526670B (en) | Traditional Chinese medicinal composition for treating cholecystitis and preparation method thereof | |
| CN102406798B (en) | Chinese medicinal composition for treating myasthenia gravis | |
| CN101543621B (en) | Drug for curing diabetes | |
| CN100586460C (en) | Oral Chinese medicine composition for treating gout | |
| CN104984303A (en) | Traditional Chinese medicine composite for treating child jaundice | |
| CN101698078A (en) | Traditional Chinese medicine for treating septicemia | |
| CN102940745B (en) | Pill for treating blepharospasm | |
| CN102727830B (en) | Traditional Chinese medicine calculus removing capsules | |
| CN104524406A (en) | Medicine for treating chronic gastritis | |
| CN103977379A (en) | Traditional Chinese medicine preparation for treating bile reflux gastritis | |
| CN103610893B (en) | A kind of Chinese medicine for the treatment of coronary heart disease | |
| CN105055964A (en) | Traditional Chinese medicine composition for treating uremia | |
| CN104922499A (en) | Traditional Chinese medicine for treating hepatitis | |
| CN100534468C (en) | Orally-administered traditional Chinese medicine for treating irritable bowel syndrome | |
| CN104352808A (en) | Traditional Chinese medicine water-honeyed pills for treating ovarian cancer | |
| CN102988845B (en) | Chinese medicine composition for treating hyperplasia of prostate and preparation method of Chinese medicine composition | |
| CN105106692A (en) | Traditional Chinese medicinal composition for gallstone postoperative recovery and preparation method of traditional Chinese medicinal composition | |
| CN104367862A (en) | Traditional Chinese medicinal composition for treating urethral calculus | |
| CN104784649A (en) | Traditional Chinese medicine decoction for treating scapulohumeral periarthritis | |
| CN104888091A (en) | Traditional Chinese medicine composition for treating intestinal form of acute radiation sickness and preparation method of traditional Chinese medicine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |